Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 78
13
Diseases
38
Unique genes
0.212
Avg. similarity score
hereditary pheochromocytoma-paraganglioma
Most-connected disease (10 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
hereditary pheochromocytoma-paraganglioma
Carney-stratakis syndrome
Paraganglioma
Pheochromocytoma/paraganglioma syndrome
Cowden disease
Carney complex
Carcinoid syndrome
Intestinal cancer
Pheochromocytoma
Skeletal muscle disorder
Polydactyly-macrocephaly syndrome
congenital dyserythropoietic anemia type 2
cowden syndrome 6
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| hereditary pheochromocytoma-paraganglioma | 10 | 10 | 7 |
| Carney-stratakis syndrome | 9 | 9 | 4 |
| Paraganglioma | 9 | 9 | 8 |
| Pheochromocytoma/paraganglioma syndrome | 8 | 8 | 8 |
| Cowden disease | 7 | 7 | 9 |
| Carney complex | 6 | 6 | 7 |
| Carcinoid syndrome | 5 | 5 | 1 |
| Intestinal cancer | 5 | 5 | 1 |
| Pheochromocytoma | 5 | 5 | 16 |
| Skeletal muscle disorder | 4 | 4 | 4 |
| Polydactyly-macrocephaly syndrome | 2 | 2 | 1 |
| congenital dyserythropoietic anemia type 2 | 1 | 1 | 1 |
| cowden syndrome 6 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| SDHD | 8 / 13 | Carcinoid syndrome, Carney-stratakis syndrome, Cowden disease, hereditary pheochromocytoma-paraganglioma and 4 more |
| SDHB | 7 / 13 | Carney complex, Carney-stratakis syndrome, Cowden disease, hereditary pheochromocytoma-paraganglioma and 3 more |
| SDHA | 6 / 13 | Carney complex, Carney-stratakis syndrome, hereditary pheochromocytoma-paraganglioma, Paraganglioma and 2 more |
| SDHC | 6 / 13 | Carney complex, Carney-stratakis syndrome, Cowden disease, hereditary pheochromocytoma-paraganglioma and 2 more |
| MAX | 3 / 13 | hereditary pheochromocytoma-paraganglioma, Pheochromocytoma, Polydactyly-macrocephaly syndrome |
| SDHAF2 | 3 / 13 | hereditary pheochromocytoma-paraganglioma, Paraganglioma, Pheochromocytoma/paraganglioma syndrome |
| AKT1 | 2 / 13 | Cowden disease, cowden syndrome 6 |
| SEC23B | 2 / 13 | congenital dyserythropoietic anemia type 2, Cowden disease |
| TMEM127 | 2 / 13 | hereditary pheochromocytoma-paraganglioma, Pheochromocytoma |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Citric acid cycle (TCA cycle) | Reactome | 6 / 22 | 86.2× | 4.77e-11 | 7.41e-9 ✓ sig. |
| Citrate cycle (TCA cycle) | KEGG | 6 / 30 | 63.2× | 3.73e-10 | 4.69e-8 ✓ sig. |
| Tyrosine metabolism | KEGG | 6 / 36 | 52.7× | 1.21e-9 | 1.32e-7 ✓ sig. |
| Catecholamine biosynthesis | Reactome | 3 / 4 | 237× | 1.17e-7 | 7.49e-6 ✓ sig. |
| Dopaminergic synapse | KEGG | 7 / 132 | 16.8× | 1.57e-7 | 9.68e-6 ✓ sig. |
| Carbon metabolism | KEGG | 6 / 115 | 16.5× | 1.45e-6 | 6.75e-5 ✓ sig. |
| Parkinson disease | KEGG | 8 / 268 | 9.4× | 1.52e-6 | 6.97e-5 ✓ sig. |
| Diabetic cardiomyopathy | KEGG | 7 / 205 | 10.8× | 3.07e-6 | 1.27e-4 ✓ sig. |
| Chemical carcinogenesis - reactive oxygen species | KEGG | 7 / 227 | 9.7× | 6.02e-6 | 2.20e-4 ✓ sig. |
| Tryptophan metabolism | KEGG | 4 / 42 | 30.1× | 8.75e-6 | 3.00e-4 ✓ sig. |
| Non-alcoholic fatty liver disease | KEGG | 6 / 157 | 12.1× | 8.86e-6 | 3.04e-4 ✓ sig. |
| Enzymatic degradation of Dopamine by monoamine oxidase | Reactome | 2 / 2 | 316× | 9.75e-6 | 3.28e-4 ✓ sig. |
| Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB | Reactome | 2 / 2 | 316× | 9.75e-6 | 3.28e-4 ✓ sig. |
| Phenylalanine metabolism | KEGG | 3 / 16 | 59.3× | 1.59e-5 | 4.95e-4 ✓ sig. |
| Cocaine addiction | KEGG | 4 / 49 | 25.8× | 1.63e-5 | 5.03e-4 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| mitochondrial electron transport, succinate to ubiquinone | GO:0006121 | 5 / 5 | 492× | 2.64e-14 | 1.59e-11 ✓ sig. |
| tricarboxylic acid cycle | GO:0006099 | 7 / 33 | 104× | 3.29e-13 | 1.66e-10 ✓ sig. |
| dopamine catabolic process | GO:0042420 | 4 / 11 | 179× | 4.75e-9 | 8.90e-7 ✓ sig. |
| catecholamine biosynthetic process | GO:0042423 | 3 / 6 | 246× | 1.55e-7 | 1.74e-5 ✓ sig. |
| catecholamine metabolic process | GO:0006584 | 3 / 9 | 164× | 6.46e-7 | 5.80e-5 ✓ sig. |
| proton motive force-driven mitochondrial ATP synthesis | GO:0042776 | 4 / 64 | 30.7× | 8.46e-6 | 4.58e-4 ✓ sig. |
| serotonin biosynthetic process | GO:0042427 | 2 / 4 | 246× | 2.41e-5 | 1.03e-3 ✓ sig. |
| phosphatidylinositol 3-kinase/protein kinase B signal transduction | GO:0043491 | 4 / 92 | 21.4× | 3.57e-5 | 1.40e-3 ✓ sig. |
| retrograde neuronal dense core vesicle transport | GO:1990049 | 2 / 5 | 197× | 4.01e-5 | 1.52e-3 ✓ sig. |
| succinate metabolic process | GO:0006105 | 2 / 5 | 197× | 4.01e-5 | 1.52e-3 ✓ sig. |
| fear response | GO:0042596 | 2 / 8 | 123× | 1.12e-4 | 3.29e-3 ✓ sig. |
| dopamine biosynthetic process | GO:0042416 | 2 / 9 | 109× | 1.44e-4 | 3.97e-3 ✓ sig. |
| neuron-neuron synaptic transmission | GO:0007270 | 2 / 9 | 109× | 1.44e-4 | 3.97e-3 ✓ sig. |
| norepinephrine biosynthetic process | GO:0042421 | 2 / 9 | 109× | 1.44e-4 | 3.97e-3 ✓ sig. |
| negative regulation of epithelial to mesenchymal transition | GO:0010719 | 3 / 53 | 27.8× | 1.69e-4 | 4.49e-3 ✓ sig. |